Get 40% Off
🎁 Free Gift Friday: Copy Legendary Investors' Portfolios in One ClickCopy for Free

GE To Strategically Expand Healthcare Portfolio At RSNA 2016

Published 11/28/2016, 04:41 AM
Updated 07/09/2023, 06:31 AM

GE Healthcare – a unit of General Electric Company (NYSE:GE) – will launch 25 new products, services and digital solutions at Radiological Society of North America (RSNA) 2016.

RSNA is an international society of radiologists, medical physicists and other medical professionals. The society consists of over 54,000 members, across 136 countries worldwide. RSNA hosts the world’s premier radiology forum, bringing together around 55,000 attendees annually at McCormick (NYSE:MKC) Place in Chicago.

GE Healthcare is looking forward to improving the healthcare industry with its new innovative products and partnerships, designed to address major challenges faced by the industry. This will provide enhanced patient experience, better clinical confidence and improve productivity.

The company’s latest products include Senographe Pristina that enables the patient to adjust breast compression with a remote control. This will reduce the patients’ discomfort and addresses one of the main concerns women have regarding mammography screening.

In addition, the company’s Centricity Imaging Collaboration Suite will enable healthcare professionals to view, manipulate and share images beyond their department. This system is build using GE Health Cloud, which helps healthcare teams collaborate on cases, reducing operation costs and improve efficiency. There are many more such launches and enhancements that the company is looking forward to showcase in the RSNA 2016, which is being held till Dec 1.

Per President and CEO of GE Healthcare John Flannery, the company is looking forward to launching a wide array of new products and software technologies to enhance performance, clinical outcomes and productivity for the healthcare industry.

3rd party Ad. Not an offer or recommendation by Investing.com. See disclosure here or remove ads .

The launch of these innovative products and services will help the company set itself apart from its peers in the healthcare industry. In turn, such innovations will augment its top line going forward.

We continue to be bullish on the strategic expansions in the healthcare ecosystem of this Zacks Rank #4 (Sell) stock. Some better-ranked stocks in this industry include Macquarie Infrastructure Corp. (NYSE:MIC) , AO Smith Corp. (NYSE:AOS) and Danaher Corp. (NYSE:DHR) , each carrying a Zacks Rank #2 (Buy). You can see the complete list of today’s Zacks #1 Rank (Strong Buy) stocks here.

Macquarie Infrastructure is currently trading at a forward P/E of 69.9x and has beaten estimates twice in the trailing four quarters for an average earnings surprise of 29.6%.

AO Smith has a long-term earnings growth expectation of 10.7% and is currently trading at a forward P/E of 26.8x.

Danaher has long-term earnings growth expectation of 11.8% and is currently trading at a forward P/E of 22.2x.

Zacks’ Best Private Investment Ideas

In addition to the recommendations that are available to the public on our website, how would you like to follow all Zacks' private buys and sells in real time? Our experts cover all kinds of trades… from value to momentum . . . from stocks under $10 to ETF and option moves . . . from stocks that corporate insiders are buying up to companies that are about to report positive earnings surprises. You can even look inside exclusive portfolios that are normally closed to new investors. Starting today, for the next month, you can have unrestricted access. Click here for Zacks' private trades >>

3rd party Ad. Not an offer or recommendation by Investing.com. See disclosure here or remove ads .


DANAHER CORP (DHR): Free Stock Analysis Report

GENL ELECTRIC (GE): Free Stock Analysis Report

MACQUARIE INFRA (MIC): Free Stock Analysis Report

SMITH (AO) CORP (AOS): Free Stock Analysis Report

Original post

Zacks Investment Research

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.